Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study

Keyphrases

• Mild Hypoglycemia 100%
• Orally Administered 100%
• Prospective Survey 100%
• Glucagon 100%
• Hypoglycemia 37%
• Type I Diabetes 25%
• Type 1 Diabetes Mellitus (T1DM) 25%
• Copenhagen 12%
• Weight Gain 12%
• High Risk 12%
• University Hospital 12%
• Diabetes 12%
• Hemoglobin A1c (HbA1c) 12%
• Glycemic Control 12%
• Treatment Modalities 12%
• Possible Causes 12%
• Subcutaneous Injection 12%
• New Treatment Options 12%
• Intensive Insulin Therapy 12%
• Patient Treatment 12%
• Academy 12%
• Novo Nordisk 12%
• Hypoglycemia Symptoms 12%
• Survey Period 12%
• Preference Pattern 12%

Neuroscience

• Hypoglycemia 100%
• Glucagon 100%
• Body Mass Index 8%
• Hemoglobin A1c 8%

Biochemistry, Genetics and Molecular Biology

• Low Drug Dose 100%
• Glucagon 100%
• Glycemic Control 14%